Project
Illumina Body Map 2
Navigation
Downloads
Results for ZNF384
Z-value: 1.36
Motif logo
Transcription factors associated with ZNF384
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF384
|
ENSG00000126746.13 | zinc finger protein 384 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF384 | hg19_v2_chr12_-_6798025_6798102 | 0.34 | 5.7e-02 | Click! |
Activity profile of ZNF384 motif
Sorted Z-values of ZNF384 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_+_101988627 | 2.35 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
| chr2_+_1418154 | 2.25 |
ENST00000423320.1
ENST00000382198.1 |
TPO
|
thyroid peroxidase |
| chr12_+_101988774 | 2.24 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
| chr4_-_159956333 | 2.03 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
| chr7_+_117864708 | 1.98 |
ENST00000357099.4
ENST00000265224.4 ENST00000486422.1 ENST00000417525.1 |
ANKRD7
|
ankyrin repeat domain 7 |
| chr6_-_26027480 | 1.97 |
ENST00000377364.3
|
HIST1H4B
|
histone cluster 1, H4b |
| chr1_+_156308403 | 1.95 |
ENST00000481479.1
ENST00000368252.1 ENST00000466306.1 ENST00000368251.1 |
TSACC
|
TSSK6 activating co-chaperone |
| chr17_+_4487294 | 1.91 |
ENST00000338859.4
|
SMTNL2
|
smoothelin-like 2 |
| chr1_-_238649319 | 1.88 |
ENST00000400946.2
|
RP11-371I1.2
|
long intergenic non-protein coding RNA 1139 |
| chrX_-_49965663 | 1.84 |
ENST00000376056.2
ENST00000376058.2 ENST00000358526.2 |
AKAP4
|
A kinase (PRKA) anchor protein 4 |
| chr20_+_12989895 | 1.73 |
ENST00000450297.1
|
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
| chr11_+_27062502 | 1.72 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr6_-_47010061 | 1.70 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
| chrX_+_102965835 | 1.66 |
ENST00000319560.6
|
TMEM31
|
transmembrane protein 31 |
| chr5_-_101834712 | 1.66 |
ENST00000506729.1
ENST00000389019.3 ENST00000379810.1 |
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1 |
| chr5_-_101834617 | 1.60 |
ENST00000513675.1
ENST00000379807.3 |
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1 |
| chr6_+_31105426 | 1.58 |
ENST00000547221.1
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1 |
| chr7_-_143966381 | 1.55 |
ENST00000487179.1
|
CTAGE8
|
CTAGE family, member 8 |
| chr15_+_69373184 | 1.55 |
ENST00000558147.1
ENST00000440444.1 |
LINC00277
|
long intergenic non-protein coding RNA 277 |
| chr1_-_185597619 | 1.53 |
ENST00000608417.1
ENST00000436955.1 |
GS1-204I12.1
|
GS1-204I12.1 |
| chr2_+_47596287 | 1.51 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr6_-_52628271 | 1.51 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
| chr11_+_101983176 | 1.51 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
| chr2_-_118943930 | 1.47 |
ENST00000449075.1
ENST00000414886.1 ENST00000449819.1 |
AC093901.1
|
AC093901.1 |
| chr2_+_232457569 | 1.46 |
ENST00000313965.2
|
C2orf57
|
chromosome 2 open reading frame 57 |
| chr12_+_48722763 | 1.45 |
ENST00000335017.1
|
H1FNT
|
H1 histone family, member N, testis-specific |
| chr12_-_53298841 | 1.43 |
ENST00000293308.6
|
KRT8
|
keratin 8 |
| chr1_+_169079823 | 1.42 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr2_-_217560248 | 1.41 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
| chrY_-_20935572 | 1.39 |
ENST00000382852.1
ENST00000344884.4 ENST00000304790.3 |
HSFY2
|
heat shock transcription factor, Y linked 2 |
| chr8_-_133637624 | 1.39 |
ENST00000522789.1
|
LRRC6
|
leucine rich repeat containing 6 |
| chr11_+_27062272 | 1.39 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr16_+_27078219 | 1.39 |
ENST00000418886.1
|
C16orf82
|
chromosome 16 open reading frame 82 |
| chr3_-_172859017 | 1.38 |
ENST00000351008.3
|
SPATA16
|
spermatogenesis associated 16 |
| chr19_+_56368803 | 1.38 |
ENST00000587891.1
|
NLRP4
|
NLR family, pyrin domain containing 4 |
| chr1_-_205391178 | 1.34 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
| chrX_-_132095419 | 1.32 |
ENST00000370836.2
ENST00000521489.1 |
HS6ST2
|
heparan sulfate 6-O-sulfotransferase 2 |
| chr11_+_27062860 | 1.32 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr1_+_38022572 | 1.31 |
ENST00000541606.1
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr7_+_117864815 | 1.27 |
ENST00000433239.1
|
ANKRD7
|
ankyrin repeat domain 7 |
| chr17_-_10325261 | 1.26 |
ENST00000403437.2
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal |
| chrX_-_110513703 | 1.23 |
ENST00000324068.1
|
CAPN6
|
calpain 6 |
| chr12_-_7245125 | 1.21 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
| chr7_+_134551583 | 1.19 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
| chr21_-_10990888 | 1.19 |
ENST00000298232.7
|
TPTE
|
transmembrane phosphatase with tensin homology |
| chr6_-_46620522 | 1.18 |
ENST00000275016.2
|
CYP39A1
|
cytochrome P450, family 39, subfamily A, polypeptide 1 |
| chr20_+_12989822 | 1.18 |
ENST00000378194.4
|
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
| chr1_-_120311517 | 1.18 |
ENST00000369406.3
ENST00000544913.2 |
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
| chrX_-_142605301 | 1.17 |
ENST00000370503.2
|
SPANXN3
|
SPANX family, member N3 |
| chr16_+_80574854 | 1.17 |
ENST00000305904.6
ENST00000568035.1 |
DYNLRB2
|
dynein, light chain, roadblock-type 2 |
| chr3_+_46618727 | 1.17 |
ENST00000296145.5
|
TDGF1
|
teratocarcinoma-derived growth factor 1 |
| chr2_-_177502659 | 1.16 |
ENST00000295549.4
|
AC017048.3
|
long intergenic non-protein coding RNA 1116 |
| chr5_+_137203465 | 1.13 |
ENST00000239926.4
|
MYOT
|
myotilin |
| chr7_+_143268894 | 1.12 |
ENST00000420911.2
|
CTAGE15
|
cTAGE family member 15 |
| chr11_+_125658006 | 1.12 |
ENST00000445202.1
|
PATE3
|
prostate and testis expressed 3 |
| chrX_+_105937068 | 1.11 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
| chr9_+_92219919 | 1.10 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
| chr2_+_79252822 | 1.10 |
ENST00000272324.5
|
REG3G
|
regenerating islet-derived 3 gamma |
| chr21_-_43735628 | 1.09 |
ENST00000291525.10
ENST00000518498.1 |
TFF3
|
trefoil factor 3 (intestinal) |
| chr1_+_156308245 | 1.08 |
ENST00000368253.2
ENST00000470342.1 ENST00000368254.1 |
TSACC
|
TSSK6 activating co-chaperone |
| chr20_-_29978383 | 1.08 |
ENST00000339144.3
ENST00000376321.3 |
DEFB119
|
defensin, beta 119 |
| chr19_-_8809139 | 1.08 |
ENST00000324436.3
|
ACTL9
|
actin-like 9 |
| chrX_+_105192423 | 1.08 |
ENST00000540278.1
|
NRK
|
Nik related kinase |
| chr7_-_37956409 | 1.08 |
ENST00000436072.2
|
SFRP4
|
secreted frizzled-related protein 4 |
| chr17_-_10452929 | 1.07 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr4_-_153700864 | 1.07 |
ENST00000304337.2
|
TIGD4
|
tigger transposable element derived 4 |
| chr4_+_175839506 | 1.07 |
ENST00000505141.1
ENST00000359240.3 ENST00000445694.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
| chr6_+_112375275 | 1.07 |
ENST00000368666.2
ENST00000604763.1 ENST00000230529.5 |
WISP3
|
WNT1 inducible signaling pathway protein 3 |
| chr6_-_28321971 | 1.07 |
ENST00000396838.2
ENST00000426434.1 ENST00000434036.1 ENST00000439628.1 |
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
| chr6_-_166401402 | 1.05 |
ENST00000581850.1
ENST00000444465.1 |
LINC00473
|
long intergenic non-protein coding RNA 473 |
| chr2_-_113993020 | 1.05 |
ENST00000465084.1
|
PAX8
|
paired box 8 |
| chr5_-_150948414 | 1.04 |
ENST00000261800.5
|
FAT2
|
FAT atypical cadherin 2 |
| chr8_-_39695719 | 1.04 |
ENST00000347580.4
ENST00000379853.2 ENST00000521880.1 |
ADAM2
|
ADAM metallopeptidase domain 2 |
| chr12_+_56075330 | 1.04 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
| chr12_-_7245018 | 1.04 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
| chr8_+_13424352 | 1.04 |
ENST00000297324.4
|
C8orf48
|
chromosome 8 open reading frame 48 |
| chr3_-_112329110 | 1.03 |
ENST00000479368.1
|
CCDC80
|
coiled-coil domain containing 80 |
| chr14_-_60952739 | 1.03 |
ENST00000555476.1
ENST00000321731.3 |
C14orf39
|
chromosome 14 open reading frame 39 |
| chr2_+_79252804 | 1.03 |
ENST00000393897.2
|
REG3G
|
regenerating islet-derived 3 gamma |
| chr9_-_107754034 | 1.03 |
ENST00000457720.1
|
RP11-217B7.3
|
RP11-217B7.3 |
| chr2_-_183291741 | 1.03 |
ENST00000351439.5
ENST00000409365.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
| chr1_+_38022513 | 1.02 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr10_-_91316398 | 1.02 |
ENST00000475682.1
|
SLC16A12
|
solute carrier family 16, member 12 |
| chrX_-_104465358 | 1.02 |
ENST00000372578.3
ENST00000372575.1 ENST00000413579.1 |
TEX13A
|
testis expressed 13A |
| chr2_-_211168332 | 1.01 |
ENST00000341685.4
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
| chr15_+_63050785 | 1.01 |
ENST00000472902.1
|
TLN2
|
talin 2 |
| chr22_-_22901477 | 1.00 |
ENST00000420709.1
ENST00000398741.1 ENST00000405655.3 |
PRAME
|
preferentially expressed antigen in melanoma |
| chr15_-_54051831 | 0.99 |
ENST00000557913.1
ENST00000360509.5 |
WDR72
|
WD repeat domain 72 |
| chr6_-_52668605 | 0.99 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
| chr8_-_19102999 | 0.99 |
ENST00000517949.1
|
RP11-1080G15.1
|
RP11-1080G15.1 |
| chr12_-_7245152 | 0.99 |
ENST00000542220.2
|
C1R
|
complement component 1, r subcomponent |
| chr3_-_58523010 | 0.99 |
ENST00000459701.2
ENST00000302819.5 |
ACOX2
|
acyl-CoA oxidase 2, branched chain |
| chr4_+_175839551 | 0.98 |
ENST00000404450.4
ENST00000514159.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
| chr4_+_41258786 | 0.97 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
| chr3_+_57094469 | 0.97 |
ENST00000334325.1
|
SPATA12
|
spermatogenesis associated 12 |
| chr2_-_238322800 | 0.97 |
ENST00000392004.3
ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3
|
collagen, type VI, alpha 3 |
| chr4_+_175839517 | 0.97 |
ENST00000502940.1
ENST00000502305.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
| chr4_-_147043058 | 0.97 |
ENST00000512063.1
ENST00000507726.1 |
RP11-6L6.3
|
long intergenic non-protein coding RNA 1095 |
| chrX_-_80457385 | 0.97 |
ENST00000451455.1
ENST00000436386.1 ENST00000358130.2 |
HMGN5
|
high mobility group nucleosome binding domain 5 |
| chr5_+_140593509 | 0.97 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
| chr18_+_47088401 | 0.97 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr5_-_74532696 | 0.96 |
ENST00000506364.2
ENST00000274361.3 |
ANKRD31
|
ankyrin repeat domain 31 |
| chr5_+_134303591 | 0.96 |
ENST00000282611.6
|
CATSPER3
|
cation channel, sperm associated 3 |
| chr1_+_47137445 | 0.96 |
ENST00000569393.1
ENST00000334122.4 ENST00000415500.1 |
TEX38
|
testis expressed 38 |
| chr19_-_50266580 | 0.96 |
ENST00000246801.3
|
TSKS
|
testis-specific serine kinase substrate |
| chrX_+_114524275 | 0.95 |
ENST00000371921.1
ENST00000451986.2 ENST00000371920.3 |
LUZP4
|
leucine zipper protein 4 |
| chr2_+_234637754 | 0.95 |
ENST00000482026.1
ENST00000609767.1 |
UGT1A3
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A3 UDP glucuronosyltransferase 1 family, polypeptide A8 |
| chr12_+_101962128 | 0.95 |
ENST00000550514.1
|
MYBPC1
|
myosin binding protein C, slow type |
| chr20_+_12989596 | 0.95 |
ENST00000434210.1
ENST00000399002.2 |
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
| chr8_-_124741451 | 0.94 |
ENST00000520519.1
|
ANXA13
|
annexin A13 |
| chr5_-_41261540 | 0.94 |
ENST00000263413.3
|
C6
|
complement component 6 |
| chr3_-_196242233 | 0.94 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
| chr1_+_201979645 | 0.94 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chrX_+_23928500 | 0.93 |
ENST00000435707.1
|
CXorf58
|
chromosome X open reading frame 58 |
| chrX_+_151081351 | 0.93 |
ENST00000276344.2
|
MAGEA4
|
melanoma antigen family A, 4 |
| chr17_-_15469590 | 0.93 |
ENST00000312127.2
|
CDRT1
|
CMT duplicated region transcript 1; Uncharacterized protein |
| chr21_+_40817749 | 0.93 |
ENST00000380637.3
ENST00000380634.1 ENST00000458295.1 ENST00000440288.2 ENST00000380631.1 |
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
| chr9_-_35689900 | 0.92 |
ENST00000378300.5
ENST00000329305.2 ENST00000360958.2 |
TPM2
|
tropomyosin 2 (beta) |
| chr8_+_92114873 | 0.92 |
ENST00000343709.3
ENST00000448384.2 |
LRRC69
|
leucine rich repeat containing 69 |
| chr19_+_42349092 | 0.92 |
ENST00000269945.3
ENST00000596258.1 |
DMRTC2
|
DMRT-like family C2 |
| chr20_+_238357 | 0.92 |
ENST00000382376.3
|
DEFB132
|
defensin, beta 132 |
| chr17_+_4487816 | 0.91 |
ENST00000389313.4
|
SMTNL2
|
smoothelin-like 2 |
| chr19_+_8953269 | 0.91 |
ENST00000305625.2
|
MBD3L1
|
methyl-CpG binding domain protein 3-like 1 |
| chr2_+_149974684 | 0.91 |
ENST00000450639.1
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
| chr21_-_28338732 | 0.91 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
| chr21_-_34542541 | 0.91 |
ENST00000451980.2
|
C21orf54
|
chromosome 21 open reading frame 54 |
| chr10_+_127661942 | 0.91 |
ENST00000417114.1
ENST00000445510.1 ENST00000368691.1 |
FANK1
|
fibronectin type III and ankyrin repeat domains 1 |
| chrX_+_37850026 | 0.90 |
ENST00000341016.3
|
CXorf27
|
chromosome X open reading frame 27 |
| chr7_-_126892303 | 0.90 |
ENST00000358373.3
|
GRM8
|
glutamate receptor, metabotropic 8 |
| chr7_-_88425025 | 0.90 |
ENST00000297203.2
|
C7orf62
|
chromosome 7 open reading frame 62 |
| chr11_+_114168085 | 0.90 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr12_-_54867352 | 0.90 |
ENST00000305879.5
|
GTSF1
|
gametocyte specific factor 1 |
| chr6_-_24358264 | 0.90 |
ENST00000378454.3
|
DCDC2
|
doublecortin domain containing 2 |
| chrX_+_49216659 | 0.90 |
ENST00000415752.1
|
GAGE12I
|
G antigen 12I |
| chr5_+_140514782 | 0.89 |
ENST00000231134.5
|
PCDHB5
|
protocadherin beta 5 |
| chr12_-_7245080 | 0.89 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
| chr12_+_110011571 | 0.88 |
ENST00000539696.1
ENST00000228510.3 ENST00000392727.3 |
MVK
|
mevalonate kinase |
| chr20_+_207892 | 0.88 |
ENST00000246105.4
|
DEFB129
|
defensin, beta 129 |
| chr16_+_68678892 | 0.88 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr5_-_35938674 | 0.88 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
| chr4_-_150736962 | 0.88 |
ENST00000502345.1
ENST00000510975.1 ENST00000511993.1 |
RP11-526A4.1
|
RP11-526A4.1 |
| chr8_-_7343922 | 0.88 |
ENST00000335479.2
|
DEFB106B
|
defensin, beta 106B |
| chr15_+_22382382 | 0.88 |
ENST00000328795.4
|
OR4N4
|
olfactory receptor, family 4, subfamily N, member 4 |
| chr4_-_110723134 | 0.88 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
| chr1_-_198509804 | 0.87 |
ENST00000489986.1
ENST00000367382.1 |
ATP6V1G3
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
| chr4_+_186347388 | 0.87 |
ENST00000511138.1
ENST00000511581.1 |
C4orf47
|
chromosome 4 open reading frame 47 |
| chr6_-_169364429 | 0.87 |
ENST00000444586.1
|
RP3-495K2.3
|
RP3-495K2.3 |
| chr12_-_48963829 | 0.87 |
ENST00000301046.2
ENST00000549817.1 |
LALBA
|
lactalbumin, alpha- |
| chr5_+_137203557 | 0.87 |
ENST00000515645.1
|
MYOT
|
myotilin |
| chr5_+_127039075 | 0.86 |
ENST00000514853.2
|
CTC-228N24.1
|
CTC-228N24.1 |
| chr9_-_95166976 | 0.86 |
ENST00000447356.1
|
OGN
|
osteoglycin |
| chr2_-_219906220 | 0.85 |
ENST00000458526.1
ENST00000409865.3 ENST00000410037.1 ENST00000457968.1 ENST00000436631.1 ENST00000341552.5 ENST00000441968.1 ENST00000295729.2 |
CCDC108
|
coiled-coil domain containing 108 |
| chr12_+_100867486 | 0.85 |
ENST00000548884.1
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
| chr7_-_143454789 | 0.85 |
ENST00000470691.2
|
CTAGE6
|
CTAGE family, member 6 |
| chr19_-_55653259 | 0.85 |
ENST00000593194.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_-_79472365 | 0.85 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
| chr18_-_53804580 | 0.85 |
ENST00000590484.1
ENST00000589293.1 ENST00000587904.1 ENST00000591974.1 |
RP11-456O19.4
|
RP11-456O19.4 |
| chr8_-_40200877 | 0.85 |
ENST00000521030.1
|
CTA-392C11.1
|
CTA-392C11.1 |
| chr22_-_40289759 | 0.84 |
ENST00000325157.6
|
ENTHD1
|
ENTH domain containing 1 |
| chr5_-_135290651 | 0.84 |
ENST00000522943.1
ENST00000514447.2 |
LECT2
|
leukocyte cell-derived chemotaxin 2 |
| chr12_+_100867733 | 0.84 |
ENST00000546380.1
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
| chr9_-_95166841 | 0.84 |
ENST00000262551.4
|
OGN
|
osteoglycin |
| chr12_+_100867694 | 0.84 |
ENST00000392986.3
ENST00000549996.1 |
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
| chr1_-_100643765 | 0.83 |
ENST00000370137.1
ENST00000370138.1 ENST00000342895.3 |
LRRC39
|
leucine rich repeat containing 39 |
| chr3_+_94657016 | 0.83 |
ENST00000462219.1
|
LINC00879
|
long intergenic non-protein coding RNA 879 |
| chr11_-_3663502 | 0.83 |
ENST00000359918.4
|
ART5
|
ADP-ribosyltransferase 5 |
| chr14_+_101361107 | 0.83 |
ENST00000553584.1
ENST00000554852.1 |
MEG8
|
maternally expressed 8 (non-protein coding) |
| chr12_-_111358372 | 0.83 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
| chr1_-_182921119 | 0.83 |
ENST00000423786.1
|
SHCBP1L
|
SHC SH2-domain binding protein 1-like |
| chr6_+_76599809 | 0.82 |
ENST00000430435.1
|
MYO6
|
myosin VI |
| chr22_-_29107919 | 0.82 |
ENST00000434810.1
ENST00000456369.1 |
CHEK2
|
checkpoint kinase 2 |
| chr12_+_32638897 | 0.82 |
ENST00000531134.1
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
| chr1_+_43637996 | 0.82 |
ENST00000528956.1
ENST00000529956.1 |
WDR65
|
WD repeat domain 65 |
| chrX_+_37026432 | 0.82 |
ENST00000358047.3
|
FAM47C
|
family with sequence similarity 47, member C |
| chr10_-_75118611 | 0.82 |
ENST00000355577.3
ENST00000394865.1 ENST00000310715.3 ENST00000401621.2 |
TTC18
|
tetratricopeptide repeat domain 18 |
| chr6_-_31846744 | 0.82 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
| chr13_-_103019744 | 0.82 |
ENST00000437115.2
|
FGF14-IT1
|
FGF14 intronic transcript 1 (non-protein coding) |
| chr2_+_48844937 | 0.82 |
ENST00000448460.1
ENST00000437125.1 ENST00000430487.2 |
GTF2A1L
|
general transcription factor IIA, 1-like |
| chr17_+_68101117 | 0.81 |
ENST00000587698.1
ENST00000587892.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
| chr6_+_27215471 | 0.81 |
ENST00000421826.2
|
PRSS16
|
protease, serine, 16 (thymus) |
| chrX_-_140336629 | 0.81 |
ENST00000358993.2
|
SPANXC
|
SPANX family, member C |
| chr2_+_11696464 | 0.81 |
ENST00000234142.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
| chr9_-_7961080 | 0.81 |
ENST00000435444.1
|
RP11-29B9.2
|
RP11-29B9.2 |
| chr4_-_135122903 | 0.81 |
ENST00000421491.3
ENST00000529122.2 |
PABPC4L
|
poly(A) binding protein, cytoplasmic 4-like |
| chr1_-_240906911 | 0.81 |
ENST00000431139.2
|
RP11-80B9.4
|
RP11-80B9.4 |
| chrY_+_20708557 | 0.81 |
ENST00000307393.2
ENST00000309834.4 ENST00000382856.2 |
HSFY1
|
heat shock transcription factor, Y-linked 1 |
| chr6_-_49755019 | 0.81 |
ENST00000304801.3
|
PGK2
|
phosphoglycerate kinase 2 |
| chr12_+_85430110 | 0.80 |
ENST00000393212.3
ENST00000393217.2 |
LRRIQ1
|
leucine-rich repeats and IQ motif containing 1 |
| chr8_+_58106143 | 0.80 |
ENST00000521653.1
ENST00000518556.1 |
RP11-513O17.2
|
RP11-513O17.2 |
| chr8_-_82443613 | 0.80 |
ENST00000360464.4
|
FABP12
|
fatty acid binding protein 12 |
| chr6_+_28227063 | 0.80 |
ENST00000343684.3
|
NKAPL
|
NFKB activating protein-like |
| chr12_-_47219733 | 0.80 |
ENST00000547477.1
ENST00000447411.1 ENST00000266579.4 |
SLC38A4
|
solute carrier family 38, member 4 |
| chr7_+_45927956 | 0.80 |
ENST00000275525.3
ENST00000457280.1 |
IGFBP1
|
insulin-like growth factor binding protein 1 |
| chr3_-_189840223 | 0.80 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
| chr1_+_110009215 | 0.80 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
| chr12_+_48876275 | 0.79 |
ENST00000314014.2
|
C12orf54
|
chromosome 12 open reading frame 54 |
| chr6_+_46661575 | 0.79 |
ENST00000450697.1
|
TDRD6
|
tudor domain containing 6 |
| chr11_-_34533257 | 0.79 |
ENST00000312319.2
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
| chr18_-_19997878 | 0.79 |
ENST00000391403.2
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1 |
| chr7_+_90032667 | 0.79 |
ENST00000496677.1
ENST00000287916.4 ENST00000535571.1 ENST00000394604.1 ENST00000394605.2 |
CLDN12
|
claudin 12 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF384
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 2.8 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 0.6 | 2.5 | GO:0090294 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.6 | 1.8 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.6 | 2.2 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.5 | 2.0 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.5 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.5 | 1.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.4 | 1.3 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.4 | 1.7 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.4 | 2.0 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.4 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.4 | 1.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.4 | 1.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.4 | 1.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.4 | 4.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.3 | 1.0 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.3 | 2.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 | 0.3 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
| 0.3 | 1.3 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 0.3 | 0.9 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.3 | 0.9 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.3 | 1.2 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.3 | 0.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 2.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.3 | 1.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.3 | 0.8 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.3 | 6.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.3 | 1.7 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.3 | 0.5 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.3 | 0.8 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) glomerular endothelium development(GO:0072011) |
| 0.3 | 1.1 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 | 1.0 | GO:0090132 | epithelial cell migration(GO:0010631) tissue migration(GO:0090130) epithelium migration(GO:0090132) |
| 0.3 | 1.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.3 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.2 | 0.7 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.2 | 0.7 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.2 | 0.7 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.2 | 1.0 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.2 | 1.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 | 2.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 0.7 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.2 | 0.6 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.2 | 0.2 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
| 0.2 | 1.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 | 0.6 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 | 0.6 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 0.2 | 1.5 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.2 | 3.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 | 1.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.2 | 0.6 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 | 1.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.2 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 0.8 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.2 | 0.6 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
| 0.2 | 0.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.2 | 0.6 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 | 0.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 3.6 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.2 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) sinoatrial node cell development(GO:0060931) |
| 0.2 | 5.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.2 | 0.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.2 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.2 | 0.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.2 | 0.5 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.2 | 0.5 | GO:0061570 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.2 | 0.5 | GO:1904640 | response to methionine(GO:1904640) |
| 0.2 | 2.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 0.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.2 | 0.5 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
| 0.2 | 0.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.2 | 1.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 2.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 0.1 | 0.4 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.1 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.6 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 | 0.4 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 0.7 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.1 | 0.8 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
| 0.1 | 0.5 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 | 0.3 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.1 | 0.7 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 0.4 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 | 0.4 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.1 | 0.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 | 0.3 | GO:0071657 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.1 | 0.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.1 | 0.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.1 | 0.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
| 0.1 | 0.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.1 | 0.5 | GO:0060032 | notochord regression(GO:0060032) |
| 0.1 | 0.9 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.1 | 0.4 | GO:1903216 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.1 | 2.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 0.5 | GO:0071306 | cellular response to vitamin E(GO:0071306) pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.1 | 2.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 0.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 | 0.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 | 0.5 | GO:0001897 | cytolysis by symbiont of host cells(GO:0001897) |
| 0.1 | 0.6 | GO:0035993 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 0.1 | 0.3 | GO:0048627 | myoblast development(GO:0048627) |
| 0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 0.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.1 | 2.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.1 | 4.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.1 | 0.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 0.3 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 8.6 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 1.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.1 | 1.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.1 | 2.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.1 | 0.3 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.1 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
| 0.1 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.1 | 1.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 | 0.3 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.1 | 1.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 1.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 0.2 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.1 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.8 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.1 | 1.5 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 0.2 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 | 0.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 2.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.7 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 0.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 1.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 0.8 | GO:0007135 | meiosis II(GO:0007135) |
| 0.1 | 0.3 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.1 | 1.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.1 | 0.4 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.1 | 0.5 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 0.7 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.1 | 0.3 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.2 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 1.1 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.1 | 1.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 0.8 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.1 | 0.5 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.1 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 1.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.1 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 0.2 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 | 1.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.4 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 0.1 | 2.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 | 1.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 1.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.1 | 0.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 | 0.4 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
| 0.1 | 0.4 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.4 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.1 | 0.2 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 2.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 0.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.1 | 0.2 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.1 | 0.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.1 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.3 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.1 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.8 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.1 | 0.5 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.3 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.1 | 0.3 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.1 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 0.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.1 | 1.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 | 0.2 | GO:0060021 | palate development(GO:0060021) |
| 0.1 | 0.2 | GO:0035938 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) positive regulation of estrogen secretion(GO:2000863) regulation of estradiol secretion(GO:2000864) positive regulation of estradiol secretion(GO:2000866) |
| 0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 | 0.2 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.1 | 0.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.1 | 0.4 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.1 | 0.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.1 | 0.1 | GO:0036146 | response to mycotoxin(GO:0010046) cellular response to mycotoxin(GO:0036146) |
| 0.1 | 0.4 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.1 | 0.2 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 0.1 | 0.1 | GO:0017143 | insecticide metabolic process(GO:0017143) |
| 0.1 | 0.2 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.1 | 1.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 | 0.6 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 0.2 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 1.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 0.8 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.1 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 0.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 | 0.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.1 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 | 0.3 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.1 | 0.2 | GO:0019860 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) beta-alanine metabolic process(GO:0019482) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) |
| 0.1 | 0.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 0.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 1.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
| 0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.1 | 0.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.1 | 0.3 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.1 | 0.3 | GO:1990834 | response to odorant(GO:1990834) |
| 0.1 | 0.3 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 | 0.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.0 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.0 | 0.3 | GO:0045995 | regulation of embryonic development(GO:0045995) |
| 0.0 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 | 1.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.0 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.0 | 0.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.0 | 1.8 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 | 0.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.0 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.0 | 0.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 0.3 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.0 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.0 | 0.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.0 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.0 | 0.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.0 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 0.6 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.0 | 0.2 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.0 | 0.2 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
| 0.0 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.0 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.0 | 0.3 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.0 | 0.5 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.0 | 0.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.0 | 0.2 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 | 0.9 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.0 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.0 | 0.2 | GO:0022007 | neural plate morphogenesis(GO:0001839) neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in gastrulation(GO:0060027) |
| 0.0 | 0.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.0 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.0 | 3.0 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.0 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.0 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.0 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
| 0.0 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
| 0.0 | 0.6 | GO:0072189 | ureter development(GO:0072189) |
| 0.0 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 0.2 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.0 | 0.1 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
| 0.0 | 10.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 | 0.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.2 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 | 0.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.0 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
| 0.0 | 0.2 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.0 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 1.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.3 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 | 1.3 | GO:0017144 | drug metabolic process(GO:0017144) |
| 0.0 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
| 0.0 | 0.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 0.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
| 0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 | 0.1 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.0 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.1 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.0 | 0.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.0 | 1.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 2.2 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.0 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.0 | 0.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.0 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.0 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.0 | 0.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 | 0.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.0 | 0.1 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.0 | 0.1 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.0 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.0 | 0.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.0 | 0.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.0 | 1.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.0 | 0.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 1.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.0 | 0.0 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.0 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 | 2.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
| 0.0 | 0.6 | GO:0051170 | nuclear import(GO:0051170) |
| 0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
| 0.0 | 0.6 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.0 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.0 | 0.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.0 | 0.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.0 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 1.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.1 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.0 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.0 | 0.1 | GO:0007623 | circadian rhythm(GO:0007623) |
| 0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
| 0.0 | 0.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.0 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 | 0.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.0 | 0.2 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.0 | 0.3 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.0 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.0 | 0.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |